PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention
- 1 October 1999
- Vol. 54 (4) , 700-705
- https://doi.org/10.1016/s0090-4295(99)00229-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapyCancer, 1996
- Prostate cancer and radiation therapy—The message conveyed by serum prostate-specific antigenInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Prostate Specific Antigen Following Radiotherapy for Local Prostate CancerJournal of Urology, 1995
- SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMYUrologic Clinics of North America, 1993
- Prostate-specific antigen density: A new prognostic indicator for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapyCancer, 1993
- Localized prostate cancer: use of serial prostate-specific antigen measurements during radiation therapy.Radiology, 1992
- Prostate Specific Antigen Levels After Radical Prostatectomy in Patients with Organ Confined and Locally Extensive Prostate CancerJournal of Urology, 1992
- A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989